GZ402668 / Sanofi - LARVOL DELTA

A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 (clinicaltrials.gov) - P=N/A | N=64 | Completed | Sponsor: Genzyme, a Sanofi Company | Active, not recruiting ➔ Completed

Trial completion • CNS Disorders • Multiple Sclerosis

A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 (clinicaltrials.gov) - P=N/A; N=54; Active, not recruiting; Sponsor: Genzyme, a Sanofi Company; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed